Project information
NISCI - Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial
(NISCI)
- Project Identification
- 681094
- Project Period
- 1/2016 - 6/2023
- Investor / Pogramme / Project type
-
European Union
- Horizon 2020
- Health, demographic change and wellbeing (Societal Challenges)
- MU Faculty or unit
- Faculty of Medicine
- Cooperating Organization
-
University Hospital Prague - Motol
Ruhr-Universität Bochum
Universität Zürich
- Responsible person Sofia Karakostas
Heidelberg University Hospital
Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.
Publications
Total number of publications: 2
2021
-
Generic acquisition protocol for quantitative MRI of the spinal cord
Nature Protocols, year: 2021, volume: 16, edition: 10, DOI
-
Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers
Scientific Data, year: 2021, volume: 8, edition: 1, DOI